RHO and neoplasm: NG2 also activates the Rho/ROCK pathway leading to effective amoeboid invasiveness of tumour cells which is characterised by excessive blebbing and enhanced actomyosin contractility (Sahai and Marshall, 2003; Paňková et al., 2012).